Inhibrx Biosciences, Inc. INBX Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Inhibrx Biosciences, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Inhibrx Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Inhibrx Biosciences, Inc.'s operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Inhibrx Biosciences, Inc.'s operating margin?
- Inhibrx Biosciences, Inc. (INBX) reported operating margin of -10,386.5% in Q4 2025.
- How has Inhibrx Biosciences, Inc.'s operating margin changed year-over-year?
- Inhibrx Biosciences, Inc.'s operating margin increased by 93.7% year-over-year, from -165,724% to -10,386.5%.
- What is the long-term trend for Inhibrx Biosciences, Inc.'s operating margin?
- Over 2 years (2023 to 2025), Inhibrx Biosciences, Inc.'s operating margin has grown at a -7.7% compound annual growth rate (CAGR), from -12,178.9% to -10,386.5%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.